Gennova Biopharmaceuticals Ltd. unveils HAMSYL Junior, marking a significant step in pediatric cancer care. This launch introduces India's first pediatric cancer medication with a Pegaspargase dosage specifically designed for children suffering from Acute Lymphoblastic Leukaemia (ALL).
